Qiagen N.V. (QGEN) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Qiagen N.V. (QGEN:NYSE), powered by AI.
- Current Price
- $37.22
- P/E Ratio
- 18.1
- Market Cap
- 7.7B
- Sector
- Healthcare
What is the Qiagen N.V. stock price forecast?
Qiagen N.V. is currently trading at $37.22. View real-time AI analysis on Alpha Lenz.
What is Qiagen N.V. insider trading activity?
View the latest insider trading data for Qiagen N.V. on Alpha Lenz.
What is Qiagen N.V.'s P/E ratio?
Qiagen N.V.'s P/E ratio is 18.1.
Qiagen N.V.
NYSE · QGEN“Qiagen N.V. trades at a P/E of 18.1 (fair value) with solid ROE of 11.6%. Operating margin of 24.9% indicates strong profitability.”
Ask for details →Company Overview
Qiagen N.V. is a global life sciences company specializing in molecular diagnostics and sample preparation technologies. As a public limited liability company headquartered in the Netherlands, Qiagen focuses on delivering "Sample to Insight" solutions that enable researchers, clinical laboratories, and pharmaceutical firms to extract and interpret DNA, RNA, and protein data from biological samples. The company’s product portfolio includes more than 500 core consumable products—such as sample and assay kits—automated instruments, and advanced bioinformatics software, collectively serving applications in molecular biology, disease detection, and personalized medicine. Qiagen’s technologies are widely adopted across healthcare, academic research, and pharmaceutical development sectors, supporting critical activities ranging from basic genetic research to infectious disease diagnostics, including COVID-19 testing solutions. The company’s substantial role in advancing molecular analysis has positioned it as a significant component of various global stock indices, underscoring its market importance and reach within the biotechnology and healthcare industries.
Company Statistics
FY 2025Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“Qiagen N.V. trades at a P/E of 18.1 (fair value) with solid ROE of 11.6%. Operating margin of 24.9% indicates strong profitability.”
Ask for details →Frequently Asked Questions
Qiagen N.V. (ticker: QGEN) is a company listed on NYSE in the Healthcare sector (Diagnostics & Research). It has approximately 5,700 employees. Market cap is $7.7B.
The current price is $37.22 with a P/E ratio of 18.05x and P/B of 2.03x.
ROE is 11.57% and operating margin is 24.90%. Annual revenue is $2.1B.